Drug Shortage Report for ACT MELOXICAM

Last updated on 2020-01-09 History
Report ID 102935
Drug Identification Number 02250012
Brand name ACT MELOXICAM
Common or Proper name MELOXICAM 7.5MG
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) MELOXICAM
Strength(s) 7.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code M01AC
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-08
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-01-09
Company comments item is To Be Disc
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-01-09 English Compare
v2 2020-01-09 French Compare

Showing 1 to 2 of 2